Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hiroki Murayama, Mitsutoshi Toda, Isao Tsumiyama, Yohei Shinfuku, Tomoko Taniguchi, Yoshio Tanaka & Naotsugu Oyama. (2019) Relationship of patient background with macro- and microvascular complications: a 2-year post-marketing surveillance of vildagliptin in nearly 20,000 Japanese diabetic patients. Expert Opinion on Pharmacotherapy 20:8, pages 1037-1047.
Read now
Read now
Abdel-Hameed I. M. Ebid, Moataz Ehab, Ashraf Ismail, Sameh Soror & Mohamed Adel Mahmoud. (2019) The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. Journal of Drug Assessment 8:1, pages 115-121.
Read now
Read now
Manoj Chawla, Tae Ho Kim, Roberto C. Mirasol, Pathan Faruque, Kathryn Cooke, Peggy Hours-Zesiger & Abhijit Shete. (2018) Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia. Current Medical Research and Opinion 34:9, pages 1605-1611.
Read now
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2017) Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt – results from the GUARD study. Curr Med Res Opin 2017;33:797-801. Current Medical Research and Opinion 33:12, pages 2261-2262.
Read now
Read now
Articles from other publishers (5)
Chen Long, Yaling Tang, Jiangsheng Huang, Suo Liu & Zhenhua Xing. (2022) Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus. Frontiers in Endocrinology 13.
Crossref
Crossref
Inês H. Vieira, Luísa M. Barros, Carla F. Baptista, Dírcea M. Rodrigues & Isabel M. Paiva. (2022) Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes. Clinical Diabetes 40:1, pages 97-107.
Crossref
Crossref
Surendra Kumar. (2021) Comparison of safety and efficacy of glimepiride-metformin and vildagliptin- metformin treatment in newly diagnosed type 2 diabetic patients. Indian Journal of Endocrinology and Metabolism 25:4, pages 326.
Crossref
Crossref
Li Zang, Yin Han, Lixian Chen, Daqing Hu, Hui Jin, Nailong Yang, Xiaoyun Shi, Linlang Liang, Mingming Liu, Hong Fan, Quanmin Li & Yiming Mu. (2019) Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study. Diabetes Therapy 10:4, pages 1391-1405.
Crossref
Crossref
Richard Silbert, Alejandro Salcido-Montenegro, Rene Rodriguez-Gutierrez, Abdulrahman Katabi & Rozalina G. McCoy. (2018) Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Current Diabetes Reports 18:8.
Crossref
Crossref